Exploring NICU nurses' views of a novel genetic point‐of‐care test identifying neonates at risk of antibiotic‐induced ototoxicity: A qualitative study
Journal of Advanced Nursing · 2024
DOI: 10.1111/jan.16045 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Journal of Advanced Nursing, 2024. Verfasst von Georgia Brown und 21 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Qualitative Research, Intensive Care Units, Neonatal, Point-of-Care Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Aim
To explore the views of neonatal intensive care nursing staff on the deliverability of a novel genetic point‐of‐care test detecting a genetic variant associated with antibiotic‐induced ototoxicity.
Design
An interpretive, descriptive, qualitative interview study.
Methods
Data were collected using semi‐structured interviews undertaken between January and November 2020. Participants were neonatal intensive care nursing staff taking part in the Pharmacogenetics to Avoid Loss of Hearing trial.
Results
Thematic analysis resulted in four themes: perceived clinical utility; the golden hour; point‐of‐care device; training and support. Recommendations were made to streamline the protocol and ongoing training and support were considered key to incorporating the test into routine care.
Conclusion
Exploring the views of nurses involved in the delivery of the point‐of‐care test was essential in its implementation. By the study endpoint, all participants could see the value of routine clinical introduction of the point‐of care test. Implications for the Profession and/or Patient Care Nurses are in a key position to support the delivery of point‐of‐care genetic testing into mainstream settings. This study has implications for the successful integration of other genetic point‐of‐care tests in acute healthcare settings. Impact The study will help to tailor the training and support required for routine deployment of the genetic point‐of‐care test. The study has relevance for nurses involved in the development and delivery of genetic point‐of‐care tests in other acute hospital settings. Reporting Method This qualitative study adheres to the Standards for Reporting Qualitative Research EQUATOR guidelines and utilizes COREQ and SRQR checklists. Patient or Public Contribution All staff working on the participating neonatal intensive care units were trained to use the genetic point‐of‐care test. All inpatients on the participating units were eligible to have testing via the point‐of‐care test. The Pharmacogenetics to Avoid Loss of Hearing Patient and Public Involvement and Engagement group provided valuable feedback. Trial and Protocol Registration Registered within the University of Manchester. Ethics approval reference numbers: IRAS: 253102 REC reference: 19/NW/0400. Also registered with the ISRCTN ref: ISRCTN13704894.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
- Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
- Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
- Newborn Intensive Care Unit, Manchester University NHS Foundation Trust, Manchester, UK.
- Newborn Intensive Care Unit, Liverpool Women's Hospital, Liverpool, UK.
- Alliance Manchester Business School, University of Manchester, Manchester, UK.
ORCID-Profile: Georgia Brown
Zitieren
APA
Brown, G., Warrington, N., Ulph, F., Booth, N., Harvey, K., James, R., Tricker, K., Wilson, P., Newman, W., Mcdermott, J. H., Stoddard, D., Mahaveer, A., Turner, M., Corry, R., Garlick, J., Miele, G., Ainsworth, S., Kemp, L., Bruce, I., …, & Macleod, R. (2024). Exploring NICU nurses' views of a novel genetic point‐of‐care test identifying neonates at risk of antibiotic‐induced ototoxicity: A qualitative study. Journal of Advanced Nursing. https://doi.org/10.1111/jan.16045
Vancouver
Brown G, Warrington N, Ulph F, Booth N, Harvey K, James R, et al. Exploring NICU nurses' views of a novel genetic point‐of‐care test identifying neonates at risk of antibiotic‐induced ototoxicity: A qualitative study. Journal of Advanced Nursing. 2024. doi:10.1111/jan.16045
BibTeX
@article{Brown2024,
author = {Brown, Georgia and Warrington, Natalie and Ulph, Fiona and Booth, Nicola and Harvey, Karen and James, Rachel and Tricker, Karen and Wilson, Paul and Newman, William and Mcdermott, John Henry and Stoddard, Duncan and Mahaveer, Ajit and Turner, Mark and Corry, Rachel and Garlick, Julia and Miele, Gino and Ainsworth, Shaun and Kemp, Laura and Bruce, Iain and Body, Richard and Roberts, Peter and Macleod, Rhona},
title = {Exploring NICU nurses' views of a novel genetic point‐of‐care test identifying neonates at risk of antibiotic‐induced ototoxicity: A qualitative study},
journal = {Journal of Advanced Nursing},
year = {2024},
doi = {10.1111/jan.16045}
}
EUVIMED